Cell loss and recovery in umbilical cord blood processing: A comparison of postthaw and postwash samples

Transfusion

Volumn 45, Issue 12, 2005, Pages 1909-1916

  Laroche, Vincent ^a   McKenna, David H ^b   Moroff, Gary ^b   Schierman, Therese ^b   Kadidlo, Diane ^b   McCullough, Jeffrey ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DIMETHYL SULFOXIDE; CRYOPROTECTIVE AGENT;

ARTICLE; CD34 SELECTION; CELL LOSS; CELL NUCLEUS; CELL TRANSPLANTATION; CELL VIABILITY; COLONY FORMING UNIT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; POSTTHAW PROCESSING; THAWING; UMBILICAL CORD BLOOD; BLOOD STORAGE; CELL COUNT; CELL SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; CYTOLOGY; FETUS BLOOD; HEMATOPOIETIC STEM CELL; METHODOLOGY;

BLOOD PRESERVATION; CELL COUNT; CELL SURVIVAL; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIMETHYL SULFOXIDE; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 33644805161     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00638.x     Document Type: Article

References (32)

1. Barker JN, Wagner JE. Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol 2003;48:35-43.
2. Migliaccio AR, Adamson JW, Steven CE, et al. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000;96:2717-22.
3. Laughlin MJ, Barker J, Bambach B, et al. Hematopietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
4. Rubinstein P, Carrier C, Scaradavou A, et al. Outcome among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998;339:1565-77.
5. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002;100:1611-8.
6. Long GD, Laughlin M, Madan B, et al. Unrelated umbilical cord blood transplantation in adult patients. Biol Blood Marrow Transplant 2003;9:772-80.
7. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
8. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003;101:4233-44.
9. Broxmeyer HE, Douglas GW, Hangoc G, et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 1989;86:3828-32.
10. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-22.
11. Antonenas V, Bradstock KF, Shaw PJ. Effect of washing procedures on unrelated cord blood units for transplantation in children and adults [abstract]. ISCT; 2002; Barcelona, Spain.
12. Rogers I, Sutherland DR, Holt D, et al. Human UC-blood banking: impact of blood volume, cell separation and cryopreservation on leukocyte and CD34+ cell recovery. Cytotherapy 2001;3:269-76.
13. Alonso JM III, Regan DM, Johnson CE, et al. A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences. Cytotherapy 2001;3:429-33.
14. Goodwin HS, Grunzinger LM, Regan KA, et al. Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential. Cytotherapy 2003;5:80-6.
15. Chrysler GR, McKenna DH, Schierman T, et al. Umbilical cord blood banking. In: Broxmeyer HE, editor. Cord blood: biology, immunology, banking, clinical transplantation. Bethesda: American Association of Blood Banks; 2004. p. 219-58.
16. McKenna DH, Emrick E, Grunnes D, et al. Filtration of cord blood allows for successful engraftment [abstract]. Transfusion 2003;43(Suppl):17A.
17. Nagamura-Inoue T, Shioya M, Sugo M, et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion 2003;43:1285-94.
18. Fackler MJ, Civin CI, May WS. Up-regulation of surface CD34 expression is regulated by protein kinase C-mediated hyperphosphorylation of CD34. J Biol Chem 1992;267:17540-6.
19. Goldman JM, Th'ng KH, Park DS, et al. Collection, cryopreservation and subsequent viability of haemopoietic stem cells intended for treatment of chronic granulocytic leukaemia in blast-cell transformation. Br J Haematol 1978;40:185-95.
20. Bank HL. Rapid assessment of islet viability with acridine orange and propidium iodide. In Vitro Cell Dev Biol 1988;24:266-73.
21. Mascotti K, McCullough J, Burger SR. HPC viability measurement: trypan blue versus acridine orange and propidium iodide. Transfusion 2000;40:693-6.
22. Rowley SD, Anderson GL. Effects of DMSO exposure without cryopreservation of hematopoietic progenitor cells. Bone Marrow Transplant 1993;11:389-93.
23. Branch DR, Calderwood S, Cecutti MA, Herst R, Solh H. Hematopoietic progenitor cells are resistant to dimethyl sulfoxide toxicity. Transfusion 1994;34:887-90.
24. Woods EJ, Liu J, Derrow CW, et al. Osmometric and permeability characteristics of human placental/umbilical cord blood CD34+ cells and their application to cryopreservation. J Hematother Stem Cell Res 2000;9:161-73.
25. Rowley SD. Cryopreservation of hematopoietic cells, In: Blume KG, Forman SJ, Appelbaum FR, editors. Thomas' hematopoietic cell transplantation. 3rd ed. Malden (MA): Blackwell Publishing; 2004. p. 599-612.
26. Alessandrino EP, Bernasconi P, Caldera D, et al. Adverse events occuring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999;23:533-7.
27. McKenna DH, Wagner JE, McCullough JJ. Umbilical cord blood infusions are associated with mild reactions and are overall well-tolerated [abstract]. ISCT; 2003; Phoenix, AZ.
28. Okamoto Y, Takaue Y, Saito S, et al. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion 1993;33:578-81.
29. Zambelli A, Poggi G, Da Prada G, et al. Clinical toxicity of cryopreserved circulating progenitor cell infusions. Anticancer Res 1998;18:4705-8.
30. Davis JM, Rowley SD, Braine HG, et al. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-6.
31. Stroncek DF, Fautsch SK, Lasky LC, et al. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991;31:521-6.
32. Syme R, Bewick M, Stewart D, et al. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004;10:135-41.